Neurologic - Ipsen

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT06047444

A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study With Extension Phase to Evaluate the Efficacy and Safety of Dysport® for the Prevention of Chronic Migraine in Adult Participants

Drug

Botulinum toxin type A

Phase

Phase III

Condition

Migraine, Chronic Migraine, Headache

Keywords

Migraine | Chronic Migraine | Headache